Thomas Fekete, MD, MACP, Thomas Durant Chair and Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, offered insight to WHYY about Merck’s new drug molnupiravir, which could be the first pill to treat COVID-19. Merck has asked the U.S. Food and Drug Administration to authorize the treatment.
IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Samantha Pettigrew Discusses Gender Differences in Obstructive Sleep Apnea with Sleep-Wake Advisor
Posted June 27, 2025Samantha Pettigrew, MD, offered comments to Sleep-Wake Advisor about the growing evidence showing that sleep-related breathing disorders like obstructive sleep apnea (OSA) can present and progress differently in women.
Read MoreDr. Ajaykumar Rao Provides Perspective to HealthCentral on a New Program to Manage Type 2 Diabetes
Posted June 27, 2025Researchers have developed a new treatment program for type 2 diabetes, called GEM, which offers an individualized approach that teases out the few foods that spike blood sugar the most so patients can focus on reducing those foods without dieting.
Read More